Announced Thu, 25 Jun · 14:00 IST
Trading Window Closure for Q1 FY27 Results Period
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.6%1-day move
₹23.30
prior close
₹23.34
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.0-0.3-0.3-0.3+0.6+2.5+2.6+0.8+1.7-0.2+0.9-2.0——
Up moveDown movePending
AI summary
Vivo Bio Tech has informed BSE that the trading window for insiders, including directors, promoters, designated persons and their immediate relatives, will remain closed from July 1, 2026 until 48 hours after the company declares its unaudited standalone and consolidated financial results for Q1 FY27, ended June 30, 2026. This is a routine compliance filing under SEBI insider trading regulations to prevent any trading by insiders during the sensitive pre-results period.
Likely market impact
No direct impact on retail shareholders. Standard regulatory compliance; insiders are restricted from trading until results are announced.